Abstract:Neuropeptide W (NPW) is a novel hypothalamic peptide that activates the orphan G protein-coupled receptors, GPR7 and GPR8. Two endogenous molecular forms of NPW that consist of 23- and 30-amino acid residues were identified. Intracerebroventricular (i.c.v.) administration of NPW is known to suppress spontaneous-feeding at dark-phase and fasting-induced food intake and to decrease body weight and plasma growth hormone and to increase prolactin and corticosterone; however, little is known about its effect on other physiological functions.We examined the effects of i.c.v. administration of NPW30 (0.3 and 3 nmol) on the mean arterial pressure (MAP), heart rate (HR), and plasma norepinephrine and epinephrine in conscious rats. NPW30 (3 nmol) provoked increases in MAP (85.12 +/- 3.16 to 106.26 +/- 2.66 mm Hg) and FIR (305.75 +/- 13.76 to 428.45 +/- 26.82 beats/min) and plasma norepinephrine (138.1 +/- 18.1 to 297.2 +/- 25.9 pg/ml) and epinephrine (194.6 +/- 21.4 to 274.6 +/- 22.7 pg/ml). Intravenously administered NPW30 Q nmol) had no significant effects on MAP and HR. These results indicate that central NPW30 increases sympathetic nervous outflow and affects cardiovascular function. (c) 2006 Elsevier B.V All rights reserved.

Cardiovascular Actions of Central Neuropeptide W in Conscious Rats